Vincent Dagommer has spent most of his career in the pharmaceutical industry, including 15 years in Brazil, Switzerland and Belgium. He worked in multinational companies (Eli Lilly, Bayer, Novartis) and then at Guerbet, a leading mid-sized company in medical imaging. After 15 years in controlling positions, he moved to BD&L at Novartis in 2011. From 2010 to 2014, he was a member of the Board of Directors of Guerbet, where he became Chairman of the Audit Committee. He joined the group operationally at the end of 2013 and held positions in subsidiary management (Belgium, France), post-acquisition integration, and group transformation. He joined Truffle in February 2022 as Operating Partner. He is CFO of Artedrone, Bariatek Medical, Caranx Medical, Holistick, Piezomedic, PK Med, Skinnate, Skinosive and SpikImm. Vincent is a graduate of ESCP.